Ignite Creation Date:
2024-07-17 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481956
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-01
First Post:
2024-06-25
Brief Title:
T-DM1 Combined With CDK46 Inhibitor Ribociclib
Sponsor:
Zheng Yabing
Organization:
Zhejiang Cancer Hospital
Organization Data
Organization:
Zhejiang Cancer Hospital
Class:
OTHER
Study ID:
2023-06-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zheng Yabing
Lead Sponsor Class:
OTHER
Responsible Party:
Zheng Yabing
Responsible Party Title:
Deputy director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Zhejiang Cancer Hospital
Old Name:
None
Old Organization:
None